OPKO Health (OPK) Tops Q4 EPS by 1c
Tweet
Share
E-mail
Get Alerts OPK Hot Sheet
Price: $1.49 -3.25%
EPS Growth %: -333.3%
Financial Fact:
Selling, general and administrative: 124.85M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -333.3%
Financial Fact:
Selling, general and administrative: 124.85M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
OPKO Health (NASDAQ: OPK) reported Q4 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $181.9 million versus the consensus estimate of $177.53 million.
For earnings history and earnings-related data on OPKO Health (OPK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Frequency Electronics (FEIM) Tops Q1 EPS by 12c
- Champions Oncology (CSBR) Tops Q1 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
